Stay updated on Safety of AK001 in Clinical Trial
Sign up to get notified when there's something new on the Safety of AK001 in Clinical Trial page.

Latest updates to the Safety of AK001 in Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.4.3 is now shown, replacing the previous v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this appears to be a minor maintenance/ UI update with no impact on study details — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous v3.4.0, a minor system update with no impact on study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedShow glossary option added and metadata labels updated (e.g., capitalization of 'Last Update Submitted that Met QC Criteria' and new 'Revision: v3.4.0'). The core study content and data (eligibility criteria, outcomes) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; no changes to study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now includes a Locations section with California as a location and updates to revision v3.3.3. The older California Locations entry and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.3%

Stay in the know with updates to Safety of AK001 in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of AK001 in Clinical Trial page.